YD Bio Limited Warrants
YD Bio Ltd. engages in the development of detection and therapeutic technologies. It offers cancer detection products, regenerative ophthalmology products, and exosome science. The company was founded on February 6, 2024 and is headquartered in Taipei, Taiwan.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | -0.65 | $0 | -$298,190 |
| 2025 Q1 | -0.98 | $0 | -$490,410 |
| 2024 Q4 | 0.10 | $0 | -$365,650 |
| 2024 Q3 | 0.54 | $0 | -$21,570 |
| 2024 Q2 | 4.05 | $0 | -$592,520 |
| 2024 Q1 | -5.12 | $0 | -$629,740 |
| 2023 Q4 |
| 0.16 |
| $0 |
| -$688,420 |